Highlights Algorae Pharmaceuticals Limited

Equities

1AI

AU0000296022

Market Closed - Australian S.E. Other stock markets 20:38:51 2024-05-20 EDT			5-day change	1st Jan Change
0.011 ^AUD	0.00%		-4.35%	+10.00%

03-08	Algorae Pharmaceuticals Nears Launch of Drug Discovery Platform	MT
02-28	Algorae Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Algorae Pharmaceuticals Nears Launch of Drug Discovery Platform	03-08	MT
Algorae Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-28	CI
Algorae Pharmaceuticals Secures Agreement with HL Pharma	12-27	MT
Algorae Pharmaceuticals Enters Partnership for Developing Drug Discovery AI Platform	23-10-25	MT
Living Cell Technologies Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-30	CI
Rights Issue: 1 new share @ 0.008 AUD for 8 existing shares	23-03-22	FA
Living Cell Technologies Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-27	CI
Living Cell Technologies Limited Completes Stage One of the Planned Use of AI in NTCELL's Manufacture	22-09-15	CI
Living Cell Technologies Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-30	CI
Living Cell Technologies Limited Announces its Choroid Plexus Tissue Shipped to Sydney as NTCELL Research Advances	22-08-15	CI
Living Cell Technologies to Use Artificial Intelligence in Parkinson’s Disease Research	22-05-23	MT
Living Cell Technologies Limited Enters A New Phase in Its Research, with Artificial Intelligence to Be Applied to the Groundbreaking Research to Combat Parkinson's Disease	22-05-22	CI
Living Cell Technologies Enters Research Deal With University of Technology Sydney	22-03-30	MT
Living Cell Technologies Limited Advances Plans for A Third Clinical Trial of NTCELL in Parkinson's Disease, Following the Signing of A Research Agreement with the University of Technology Sydney and the Australian Foundation for Diabetes Research	22-03-29	CI
Living Cell Technologies Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-24	CI
Living Cell Technologies Enters Pig Tissue Services Deal for NTCELL Clinical Trial	22-01-24	MT
Rights Issue: 2 new shares @ 0.008 AUD for 3 existing shares	21-11-16	FA
Living Cell Technologies Receives R&D Tax Credit from New Zealand	21-11-09	MT
Living Cell Technologies Limited Secures Funds for 3rd Trial of NTCELL in Parkinson Disease	21-10-18	CI
Living Cell Technologies Limited Reports Earnings Results for the Full Year Ended June 30, 2021	21-08-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Algorae Pharmaceuticals Limited

Equities

1AI

AU0000296022

Highlights

Filters